POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant Genetic Test sale cost 4400 AED
HARS2 Gene Perrault Syndrome Type 2 Genetic Test sale cost 4400 AED HARS2 Gene Perrault Syndrome Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ZFHX4 Gene Ptosis Congenital Genetic Test sale cost 4400 AED ZFHX4 Gene Ptosis Congenital Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The POLG2 gene test for Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 (autosomal dominant) is a specialized genetic test available at DNA Labs UAE. This test is designed to identify mutations in the POLG2 gene, which are associated with the development of Progressive External Ophthalmoplegia (PEO) type 4. PEO is a disorder characterized by weakness of the muscles around the eyes and eyelids (leading to drooping eyelids and difficulty moving the eyes), and can also affect other muscles in the body. The autosomal dominant inheritance pattern means that a mutation in just one of the two copies of the gene can cause the condition.

The test is crucial for individuals who have a family history of PEO or show symptoms suggestive of the disorder, as it helps in confirming the diagnosis, understanding the risk of passing the mutation to offspring, and guiding management and treatment options. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the POLG2 gene.

The cost of the POLG2 gene test at DNA Labs UAE is 4400 AED. This price may cover the cost of the sample collection, genetic analysis, and the provision of a comprehensive report that explains the results. It is advisable for individuals considering this test to consult with a genetic counselor or a healthcare provider to understand the implications of the test results for themselves and their family members.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant Genetic Test

Test Name: POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POLG2 Gene Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant.

Test Details

Progressive External Ophthalmoplegia with Mitochondrial Deletions Type 4 Autosomal Dominant (PEOA4) is a genetic disorder that affects the muscles responsible for eye movement. It is caused by mutations in the POLG2 gene.

NGS (Next-Generation Sequencing) Genetic Test is a diagnostic tool used to analyze the DNA sequence of an individual’s genes. It is a high-throughput technology that can simultaneously analyze multiple genes, making it useful for identifying genetic mutations associated with various diseases.

In the case of PEOA4, an NGS Genetic Test can be used to identify mutations in the POLG2 gene. This test involves obtaining a DNA sample, usually through a blood sample, and sequencing the DNA to identify any variations or mutations in the POLG2 gene.

By identifying mutations in the POLG2 gene, healthcare professionals can confirm a diagnosis of PEOA4 and provide appropriate medical management and genetic counseling for affected individuals and their families.

Test Name POLG2 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 4 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for POLG2 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with POLG2 Gene Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant
Test Details

Progressive external ophthalmoplegia with mitochondrial deletions type 4, autosomal dominant (PEOA4) is a genetic disorder that affects the muscles responsible for eye movement. It is caused by mutations in the POLG2 gene.

NGS (Next-Generation Sequencing) Genetic Test is a diagnostic tool used to analyze the DNA sequence of an individual’s genes. It is a high-throughput technology that can simultaneously analyze multiple genes, making it useful for identifying genetic mutations associated with various diseases.

In the case of PEOA4, an NGS Genetic Test can be used to identify mutations in the POLG2 gene. This test involves obtaining a DNA sample, usually through a blood sample, and sequencing the DNA to identify any variations or mutations in the POLG2 gene.

By identifying mutations in the POLG2 gene, healthcare professionals can confirm a diagnosis of PEOA4 and provide appropriate medical management and genetic counseling for affected individuals and their families.

SKU: TEST-1944 Category:

Related products